XML 17 R7.htm IDEA: XBRL DOCUMENT v3.24.3
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 9 Months Ended
Sep. 28, 2024
Sep. 30, 2023
Operating activities:    
Net loss $ (370,824) $ (24,120)
Adjustments to reconcile net loss to cash used for operating activities:    
Depreciation and amortization 29,103 39,805
Amortization of deferred financing costs and debt discount 3,763 3,763
Impairment of franchise rights acquired 315,033  
Impairment of intangible and long-lived assets 297 197
Share-based compensation expense 7,059 12,838
Deferred tax benefit (15,905) (7,449)
Allowance for doubtful accounts 12,296 407
Reserve for inventory obsolescence 75 1,897
Foreign currency exchange rate loss (gain) 1,902 (31)
Changes in cash due to:    
Receivables 4,675 9,117
Inventories 97 9,009
Prepaid expenses 19,754 (27,301)
Accounts payable (1,718) 1,221
Accrued liabilities (14,551) (17,010)
Deferred revenue (2,745) 309
Other long term assets and liabilities, net (15,334) (2,701)
Income taxes 5,576 (1,104)
Cash used for operating activities (21,447) (1,153)
Investing activities:    
Capital expenditures (598) (2,143)
Capitalized software and website development expenditures (12,620) (26,190)
Cash paid for acquisitions, net of cash acquired   (38,362)
Other items, net (5) (14)
Cash used for investing activities (13,223) (66,709)
Financing activities:    
Taxes paid related to net share settlement of equity awards (631) (1,417)
Proceeds from stock options exercised   710
Cash paid for acquisitions (16,500) (1,178)
Other items, net (4) (43)
Cash used for financing activities (17,135) (1,928)
Effect of exchange rate changes on cash and cash equivalents (380) (1,038)
Net decrease in cash and cash equivalents (52,185) (70,828)
Cash and cash equivalents, beginning of period 109,366 178,326
Cash and cash equivalents, end of period $ 57,181 $ 107,498